CSI Market
Sign In | Register

Pure Bioscience Inc (PURE) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access PURE Annual Balance Sheets →
This balance sheet overview for Pure Bioscience Inc spans from Jul 31 2025 to Jul 31 2026, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PURE/balance-sheets
https://api.csimarket.com/api/v1/companies/PURE/fundamentals
https://api.csimarket.com/api/v1/companies/PURE/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Jul 31 2026)
(Apr 30 2026) (Jan 31 2026) (Oct 31 2025) (Jul 31 2025)
Assets
Cash & cash equivalent0.57
Restricted Cash0.08
Cash & Short-term Investments0.00
Accounts receivable0.33
Inventories0.19
Other Current Assets0.00
Prepaid Expense, Current AS0.01
Total Current Assets1.19
Equipment/Property/Plant Net1.62
Tax Assets, Noncurrent28.63
Other Assets, Noncurrent0.00
Restricted Cash Current0.08
Total Assets1.19
Liabilities
Accounts Payable, Current AC0.82
Accrued Liabilities, Current AC0.17
Convertible Notes Payable, Current NO3.38
Other Liabilities, Current0.00
Total Current Liabilities4.37
Long-term debt6.60
Convertible Notes Payable, Noncurrent LO8.99
Total Long-term Debt15.59
Other liabilities, Noncurrent0.00
Total Liabilities7.59
Stockholders' Equity
Common Stock Value1.30
Additional Paid In Capital Common Stock133.78
Retained Earnings / Accumulated Deficit-141.48
Other Equity0.00
Common Stockholder's Equity-6.40
Total Stockholder's Equity-6.40
Liabilities & Stockholder's Equity1.19
4 historic quarters locked

Sign in to unlock the full Pure Bioscience Inc balance sheet history.

Sign In Create Free Account

About Pure Bioscience Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260430)
  • Filed with the SEC: June 15, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-028691

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI